The use of streptomycin in the pathological prion protein (PrP sc ) detection procedures represents a new and attractive way for diagnostic purpose. With this agent, western blot readily detected PrP sc in 263K scrapie hamster and C57Bl/6 wild-type mice challenged with C506M3 scrapie strain. Our aim was to evaluate this new diagnosis procedure in the field of human transmissible spongiform encephalopathies (TSEs). First, we had confirmed the ability of streptomycin to precipitate PrP res from human brain of Creutzfeldt-Jakob disease (CJD) patient. Second, we compared the detection of PrP res with streptomycin against three other protocols using other precipitations. Then we assessed PrP res detection with streptomycin in 98 brain tissue samples from various aetiologies of human TSEs and 52 brain samples from other dementia. Finally, we applied this protocol for tonsils examination of five patients suspected of variant CJD (v-CJD). Sensitivity and specificity obtained with the streptomycin protocol were both 100% on brain tissue. For tonsil tissues, PrP res was clearly identified in the two post-mortem confirmed v-CJD cases, whereas no characteristic three-band pattern was seen in the three confirmed non-v-CJD samples. In this study, streptomycin demonstrated its efficiency to detect PrP res both in the central nervous system and in the lymphoid tissue without practical difficulty and with rapid preparation. Because of its ability to act as a good agent for PrP sc examination in different tissues, recovery of PrP sc in biological fluids using streptomycin should open further perspectives of applications in CJD diagnostics. Streptomycin effects in vivo might thus also be questioned.
, Armand Perret-Liaudet 1 and Hervé Perron 2, 5 The use of streptomycin in the pathological prion protein (PrP sc ) detection procedures represents a new and attractive way for diagnostic purpose. With this agent, western blot readily detected PrP sc in 263K scrapie hamster and C57Bl/6 wild-type mice challenged with C506M3 scrapie strain. Our aim was to evaluate this new diagnosis procedure in the field of human transmissible spongiform encephalopathies (TSEs). First, we had confirmed the ability of streptomycin to precipitate PrP res from human brain of Creutzfeldt-Jakob disease (CJD) patient. Second, we compared the detection of PrP res with streptomycin against three other protocols using other precipitations. Then we assessed PrP res detection with streptomycin in 98 brain tissue samples from various aetiologies of human TSEs and 52 brain samples from other dementia. Finally, we applied this protocol for tonsils examination of five patients suspected of variant CJD (v-CJD). Sensitivity and specificity obtained with the streptomycin protocol were both 100% on brain tissue. For tonsil tissues, PrP res was clearly identified in the two post-mortem confirmed v-CJD cases, whereas no characteristic three-band pattern was seen in the three confirmed non-v-CJD samples. In this study, streptomycin demonstrated its efficiency to detect PrP res both in the central nervous system and in the lymphoid tissue without practical difficulty and with rapid preparation. Because of its ability to act as a good agent for PrP sc examination in different tissues, recovery of PrP sc in biological fluids using streptomycin should open further perspectives of applications in CJD diagnostics. Streptomycin effects in vivo might thus also be questioned. The normal or native prion protein, designated as PrP c for the cellular prion protein, is a widely occurring protein, the sequence of which is well conserved in mammals. 1 Conformational changes in PrP c lead to propagation of the pathogenic prion protein 'PrP sc ' that is proteinase K (PK) resistant, at least for its core fragment, which is referred as 'resistant PrP' (PrP res ). The PrP sc accumulation in animals is associated with a wide range of diseases classified as 'transmissible spongiform encephalopathies' (TSEs). TSEs cover a series of transmissible neurodegenerative diseases, including scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease in deer and elk, and Kuru and Creutzfeldt-Jakob disease (CJD) in humans. 2 As represented by Gerstmann-Straüssler-Scheinker disease and fatal familial insomnia (FFI) in humans, TSE forms may also have genetic origins linked to mutations in the PrP gene that affect thermodynamics of the encoded protein in a spontaneous way favouring beta-sheet transconformation of PrP c to PrP sc . Consequently, a significant probability to evolve towards pathogenic propagation during the lifetime exists in individuals affected by such genetic mutations in their inherited genotype. 3, 4 Coincidently with the outbreak of BSE epidemics and the confirmed transmission by food products, a new form of human CJD appeared with original histopathological and biochemical characteristics of PrP sc , which was named 'new variant CJD' (v-CJD). 5, 6 It is now admitted that v-CJD originates from the bovine BSE epidemics by passage to humans through alimentation. 7, 8 The slow development and appearance of symptoms in cattle infected with BSE, with average incubation periods over 4-6 years, have greatly hindered the development of epidemic models as well as the reality of a passage to humans, itself hindered by an even longer period of incubation, which may last for decades. 9 Indeed, the antigenic PrP sc load is generally thought to increase progressively after infection, in lymphoid and peripheral nervous tissue and to reach the brain where its aggregation determines the fatal neuropathological issue of TSEs. 10 Thus, apart from the brain in which PrP sc accumulation is a dead end, PrP sc concentration is expected to be low in other tissues or in biological samples such as blood. 11 Today, v-CJD epidemics in humans have only clinically emerged in most susceptible individuals, ie with homozygotic methionine genotype in PrP 129 (MET-MET) codon----known to be associated with short incubation period--and with a window period of alimentary contamination during childhood, when factors such as intestinal barrier functionality are critical. 12 Recently, a novel PrP sc type in a patient exhibiting prion protein gene 129VV polymorphism was reported as atypical because of certain clinical and molecular PrP sc features overlapping with those of v-CJD. 13 Nonetheless, recent studies providing evidence of 'asymptomatic infected carriers' in the UK population, as well as the fourth case of 'highly probable' transfusional cases already reported today are in favour of a possible 'underground propagation' of PrP sc within the human population. [14] [15] [16] [17] [18] Though its reality may be considered as evidenced, its extent and its evolution in the exposed populations, within such long delays of asymptomatic incubation and with possible lifelong asymptomatic carrier cases, are still very difficult to estimate. Therefore, diagnostic tests for the detection of PrP sc infection at onset are required for an efficient control of this disease. In a research strategy for the definition of test principles suitable for the early detection of infection by PrP sc in humans, we have been interested in screening molecules for their ability to capture, concentrate and/or precipitate PrP sc . After having screened numerous molecules and devices for such properties, one of the selected molecules, streptomycin, is a well-known antibiotic and revealed capable of aggregating PrP sc molecules from different tissue origins with different stages of aggregation. 19 Streptomycin is now used to increase the sensitivity of PrP sc immunodetection using its properties to aggregate and flocculate PrP sc molecules in different tissues of animals challenged for experimental TSE. 20 Moreover, successful precipitation of human brain PrP sc with this agent was reported in feasibility studies compared with animal samples. 19, 20 These properties were also used in immunohistochemistry, giving specific and sensitive immonoreactive PrP sc deposits in both natural and experimental scrapie and BSE diagnosis. 21, 22 To ascertain the reliability and specificity of sample treatment with streptomycin for developing diagnostic detection of PrP sc in humans, we have designed a study using streptomycin followed by a reference western blot (WB) immunodetection on well-characterized reference human brain material from various forms of TSE in parallel with equivalent brain material from confirmed non-TSE patients. The protocol was also applied for tonsil tissue from v-CJD patients, in parallel with equivalent material from non-TSE patients. We thus present here the results obtained at first on a cohort of 150 patients from which necropsic human brain tissue was expertised for final TSE diagnosis confirmation by immunohistological and biochemical procedures. They represent 98 TSE cases and 52 non-TSE controls. Second, we present the results obtained on a small cohort of five patients from whom tonsil tissue was assessed for v-CJD diagnostic; two of them were further confirmed as v-CJD after post-mortem brain examination. 24 codon 129 polymorphism of the PRNP gene, 25 PrP res molecular typing 26 and aetiology are reported in Table 1 . Prion disease was rejected in the remaining 52 patients. The final diagnosis of non-TSE patients was further completed: 19 Alzheimer's disease, 4 Lewy body dementia, 4 Parkinson's disease, 2 fronto-temporal dementia and 23 others types of pathologies. For tonsil tissue, samples were obtained after tonsillectomy for diagnostic purpose of suspected v-CJD in five patients. Two patients were classified v-CJD after confirmed diagnostics carried out on brain necropsic tissues, whereas the three others were confirmed negatives for v-CJD diagnosis.
MATERIALS AND METHODS

Common Pretreatment of Samples Used in Comparative Study
To compare WB protocols on brain tissue, only available aliquot samples stored at À801C from the same brain area (prefrontal cortex) were used. In first series, 500 mg of prefrontal cortex was homogenized with distilled water at 20%. Homogenates were forced through a 0.5 mm diameter needle and divided into four aliquots for the different concentration protocols tested. In second series, with the same protocol, we prepared another homogenate from 20 mg of prefrontal cortex and divided it into four aliquots. The precipitation of PrP sc was thus compared with different techniques using a small amount (5 mg) of brain tissue.
Streptomycin Protocol (Streptomycin)
Analytical comparison of four protocols with determination of dilution limit was performed on 25 ml of the 20% homogenate (corresponding to 5 mg equivalent brain tissue) diluted twofold in phosphate-buffered saline (PBS) 2 Â (pH ¼ 7.2, DOC 1%, NP-40 1%).
For the cohort examination, 5 mg of prefrontal cortex was directly homogenized in PBS (pH ¼ 7.2) DOC 0.5%, NP-40 0.5% representing a final 10% brain homogenate. For tonsil tissues, 10% homogenates were simply made in 5% glucose. Tissues were all treated with PK (80 mg/ml) for 30 min at 371C and streptomycin (200 mg/ml) was added for 1 h at 371C as previously described. 19 Thus, after having made 10% homogenates from 5 mg of TSE brain, we used a 0.14 M final concentration of streptomycin in PK incubation medium. Samples were then submitted to centrifugation for 15 min at 17 000 g. A second centrifugation was made when a slightly milky zone was observed above the pellet. Pellets were resuspended in 4% SDS denaturating buffer (Tris HCl pH ¼ 6.8 125 mM, glycerol 20%) and boiled for 10 min at 1001C. Then, they were further processed as indicated below for WB analysis.
Ultracentrifugation Protocol
For the analytical comparison of the four protocols, 500 or 25 ml of the 20% homogenate (corresponding to 100 or 5 mg equivalent brain tissue respectively) was diluted twofold in 10% glucose.
In our laboratory, this protocol is currently performed since 1998 with 100 mg of prefrontal cortex as previously described 27 with slight modifications; prior to ultracentrifugation in Sarkosyl, homogenates were digested by proteinase K (25 mg/ml) for 1 h at 371C before stopping digestion by PMSF 1 mM.
Sodium Phosphotungstic Acid Protocol
For the analytical comparison of the four protocols, 250 or 25 ml of the 20% homogenate (corresponding to 50 or 5 mg equivalent brain tissue, respectively) was diluted twofold in PBS buffer 2 Â without Ca þ þ and Mg þ þ (pH ¼ 7.2). The protocol was strictly performed as previously described with 500 or 50 ml of 10% homogenate (50 or 5 mg) of prefrontal cortex. 28 
Centrifugation
Step Concentration Protocol (LC) For the analytical comparison of the four protocols, 40 or 25 ml of the 20% homogenate (corresponding to 8 or 5 mg equivalent brain tissue, respectively) was diluted twofold in Tris-buffered Saline 2 Â (pH ¼ 8). The protocol corresponding to the 'Sample preparation II' described by Lee et al. 29 was performed as previously described with 8 or 5 mg of prefrontal cortex.
WB Immunodetection
Each sample was analysed on 12% Nu-PAGE gels. Gels were then electroblotted on to PVDF membranes and blocked with 5% (W/V) milk powder in PBS for 1 h. Streptomycin for rapid Creutzfeldt-Jakob disease diagnosis I Quadrio et al
Immunodetection of PrP res was observed using 1/10 000 3F4 purified anti-PrP monoclonal antibody (Proteogenics, USA) for 1 h at room temperature and revealed by chemiluminescence substrate West Dura (Pierce, USA).
RESULTS
Analytical Features
As shown in Figure 1 , PrP res signal is totally collected in the pellet as no immunodetection was evidenced in the supernatant. Thus, this concentration corresponding to 0.14 M of streptomycin in PK digestion medium was adopted for following validation in human TSE brain and tonsil samples.
We then compared the ability of streptomycin concentration vs our usual technique and vs other established sensitive protocols. To observe signals on the same membrane after immunodetection, we loaded in each well 1 mg equivalent brain tissue obtained for each of the four different methods. As shown in Figure 2a , signals appeared to be slightly more important with ultracentrifugation protocol (UC) and LC protocols than with streptomycin and NaPTa protocols. Finally, for CJD Val/ Val type 2, NaPTa and UC protocols gave better PrP res signals than the two others.
In the second series, we compared the analytical sensitivity and the ability of each protocol to recover PrP sc from only 5 mg of brain tissue. As shown in Figure 3 , NaPTa and streptomycin protocols were the most efficient procedures for good recovery of PrP res in s-CJD Met/Met 1 ( Figure 3a ) and genetic CJD Met/Met 2 (Figure 3b ), whereas no significant difference was seen for s-CJD Val/Val 2 samples (Figure 3c) . Figure 4 , we also observed that NaPTa and streptomycin were the most sensitive protocols, whereas the two others were not able to detect PrP res in these diluted samples. We could also confirm that, in the cases of s-CJD Met/Met 1, s-CJD Val/Val 2 and FFI Met/Met 2, the dilution limit differed as expected from known variation of PrP sc concentration in corresponding samples. Streptomycin for rapid Creutzfeldt-Jakob disease diagnosis I Quadrio et al Cerebral PrP res Detection Using Streptomycin Precipitation All brain specimens from the 98 confirmed TSE patients showed PrP res -positive signal on WB by immunodetection with 3F4 monoclonal antibody after streptomycin precipitation. As represented in Figure 5 , the three-band PrP res pattern is clearly identified for these samples. When the signal was saturated, a smear all along the lane was found. For the specimen of the 52 non-TSE patients (examples in Figure 5 ), no signal was detected indicating that (i) the digestion of PrP c by PK was complete, and (ii) streptomycin addition did not interfere with immunodetection.
Most importantly, TSE and non-TSE patients were correctly classified by the assay leading to specificity and sensitivity at 100%.
Cerebral PrP res Molecular Typing Using Streptomycin Precipitation
The evaluation of streptomycin influence on the PrP res molecular typing was further analysed. Using streptomycin precipitation, we were able to detect the two major WB bands with distinct apparent molecular weights of unglycosylated isoform that characterized types 1 and 2 PrP res . So types 1 and 2 PrP res were clearly discriminated. Although we did not perform exact determination of the ratio diglycosylated/ monoglycosylated bands, we nevertheless examine PrP 
Tonsil Examination for PrP res Detection with Streptomycin Protocol
The type 2b PrP res was clearly identified in the two tonsils extracted from confirmed v-CJD cases (Figure 7 , lanes 4 and 5) with the characteristic three-band pattern, whereas the three non-v-CJD showed a background and nonspecific signal around 30 kDa that did not fit with any characteristic three-band pattern of PrP res ( Figure 7, lanes 1-3) . In v-CJD tonsils, the relative ratio of glycotype appeared to be consistent with that of corresponding brain extract.
DISCUSSION
The streptomycin precipitation protocol performed in this study is adapted from the one reported for brain PrP sc detection in natural scrapie, natural BSE and experimental Streptomycin for rapid Creutzfeldt-Jakob disease diagnosis I Quadrio et al BSE in mice. 19 Analysis of the supernatants after precipitation from a very low amount of human brain (5 mg) compared with that routinely used for UC (100 mg) shows that all PrP res -specific signal detected can be concentrated in the pellet, without significant residual signal in supernatant. So the full process used in animal TSE was successfully transferred to human application without modification.
Although the main objective was not a complete analytical study, we nonetheless compared this protocol with different reported processes using concentration steps as UC commonly used in our lab for CJD diagnosis, 27 a centrifugation protocol (LC) 29 and NaPTa step precipitation (NaPTa) 28 as previously described by others. In first series, these concentration protocols were tested as reported without modification prior to a unique WB analysis. Here, the amounts of tissue tested were those recommended for streptomycin, LC, NaPTa and UC protocols (5, 8, 50 and 100 mg, respectively). Thus, comparison of an equivalent quantity was achieved in WB analysis by loading 1 mg of brain tissue extract into the gel. In second series, we have compared the ability of each protocol to recover PrP res from a small amount of brain tissue equivalent to that processed in streptomycin protocol (5 mg). This reproduced situations when only small quantities of original sample material are available (ie tonsils).
From the present study, advantages and drawbacks of each protocol can be rapidly listed. Elimination of most of soluble proteins by UC allows loading high amounts of tissue (20-50 mg) without unspecific noise (not shown) but it is (i) time consuming (4 h 35 min), (ii) large serial analysis cannot be performed within 1 day and (iii) recovery of the pellet needs experience with an important impact of manipulators' skill (particularly when initial quantity is below 10 mg of tissue). Moreover, this technique revealed poor sensitivity for recovering PrP res when performed from only 5 mg of tissue, in particular for s-CJD Met/Met 1 and FFI Met/Met 2. It thus appeared to be extremely dependent upon the initial amount of tissue. With NaPTa, high recovery of PrP res in the pellet vs PrP c offers a potential to load high amounts of tissue (25-50 mg) without unspecific noise but requires (i) long sequential steps (3 h 30 min), (ii) time-consuming buffer and stock solution preparation and (iii) frequent need to solubilize a white precipitate as reported. 28 Nonetheless, NaPTa also succeeded in recovering PrP res in the different PrP sc strains tested here from 5 mg of brain tissue. Using the centrifugation method (LC), 29 centrifugation at 20 000 g reduced the preparation time (3 h 05 min) whatever the amount of tissue. However, with the recommended initial amount of 8 mg of tissue, PrP res was clearly recovered, but when decreased to only 5 mg, the sensitivity dropped. For LC, ratio of proteinase K/amount of brain tissue is the highest of the four techniques, still proteinase K concentration needed to be increased to completely digest PrP c for few cases. Finally, streptomycin concentration gave specific results with good sensitivity, with the lowest amount of tissue and the shortest preparation time (2 h 30 min). Only in few cases complete recovery of pellet required a second low-speed and short centrifugation step. In dilution experiments, the most sensitive protocols were found to be NaPTa and streptomycin.
The main objective was thereafter to evaluate the sensitivity and specificity of the streptomycin protocol in a cohort representing the diversity of human TSE types.
The results obtained here with the post-mortem diagnosed cohort of 98 TSE patients and 52 non-TSE patients yielded 100% specificity and 100% sensitivity, showing neither false positive nor false negative. This performance with such specificity provides criteria enabling the use of this new protocol for PrP res concentration. Indeed, no false negative could be admissible in the field of human TSE diagnosis. Actual sensitivity of the protocol also complies with the objective of detecting brain PrP res , for post-mortem diagnostic purposes. Thus, precipitation by streptomycin was found to be helpful in terms of practicability, and could replace a cumbersome UC method with its different drawbacks. This protocol gave similar signal than the two other methods used, ie NaPTa and LC, when the same quantities of brain tissue are loaded in the gel. For post-mortem brain diagnosis, a decrease in the amount of tissue is not a critical step. But for ante-mortem biopsies of tonsils and other tissues as reported for olfactory mucosa and in our previous study on peripheral nerves, 27, 30 processing low amounts without a good recovery of PrP sc would be a limitation for certain methods. In the case of tonsil examination in clinically suspected v-CJD cases, our results obtained with streptomycin permitted to clearly detect characteristic PrP res pattern in this lymphoid tissue. Even if a faint signal can be detected around 30 kDa on non-v-CJD tonsil samples, no characteristic pattern of PrP res can be detected on overexposed WB with these negative samples, whereas it clearly exists for positive samples (data not shown). We have noticed incidentally that freezing-thawing cycles have decreased this nonspecific signal, whereas increasing PK concentration up to twofold had no influence. Some optimization should be performed to improve specificity if single band analysis ever became relevant, but this streptomycin protocol should be sufficient for a global rapid test. These results were correlated with the confirmed diagnosis obtained after brain examination, confirming again a good sensitivity and specificity. These data, as those recently reported in C57Bl/6 mice inoculated i.c. or i.p., provide evidence that PrP res could be detected either in lymphoid organs or in brain with a good sensitivity. 31 Streptomycin seems then to be an efficient tool for peripheral tissue examination in living individuals.
The present protocol permits the recognition of the different glycoforms of human brain PrP res by 3F4 antibody with the expected shift in the molecular weight. 19 This shift does not alter the classical three-band pattern and therefore, this method complies with the molecular PrP res typing field. 23 Finally, v-CJD molecular PrP res pattern is discriminated from those found in sporadic or genetic CJD. Indeed, in our present conditions, we have worked with streptomycin quantity within the range of those shown not to increase molecular weight patterns in precipitated material from PK-digested homogenate. 19 Moreover, in another study, 20 still different patterns were reported using protocols inverting the proteinase K and streptomycin incubation steps when compared with our protocol. They thus yielded patterns diverging from our own results, which we have obtained after setting up conditions most appropriate for our study dedicated to human CJD diagnostics. Thus our analyses had to be comparable in routine conditions to other reference techniques used in the human medical domain.
In conclusion, it is the first report to our knowledge on streptomycin WB for routine diagnosis of human TSEs. Streptomycin seems to act as a good precipitation agent for low amount of tissue containing PrP sc and thus permits quick analyses on small quantities of tissues, with particular interest for biopsies. This protocol allowed us to detect PrP res in small amounts of tonsil tissue for v-CJD patients. For peroneal nerve analysis in s-CJD as already reported, 27, 32 it could also be an alternative to UC as only 20% of sensitivity was found. Streptomycin also seems to be a valid alternative protocol to NaPTa when small amounts of tissue are available. Because satisfactory recovery efficiency of PrP res spiked in CSF and urine was recently claimed, 20 it could now be evaluated as a tool for a test detecting PrP sc in human and animal biological fluids. Finally, because streptomycin is a well-known antibiotic available for human therapy, these in vitro results could raise questions about its eventual effects in vivo.
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